Award
University of Alabama at Birmingham 5R01HD113612-03
Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)
Recipient
University of Alabama at Birmingham
Award Amount
$752,645.00
Ceiling
$752,645.00
Awarded
July 28, 2026
Identifier
5R01HD113612-03
Award for a research project to evaluate continuous glucose monitoring in pregnant women with type 2 diabetes, aiming to improve maternal and neonatal outcomes through a randomized controlled trial.
Description
This is a research project funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The project aims to evaluate the effectiveness of real-time continuous glucose monitoring (CGM) in pregnant women with type 2 diabetes mellitus (T2DM) to improve maternal and neonatal outcomes. The study will be conducted across multiple sites, including the University of Alabama at Birmingham. The project involves a randomized controlled trial comparing CGM with standard blood glucose self-monitoring (SMBG). The study duration is from September 2024 to July 2029, with an award amount of approximately $752,645. The project emphasizes addressing social and structural barriers to diabetes management in disadvantaged populations.